文献速递临床微生物分子诊断

新型信号放大法快速检测并鉴别血培养中临床相关念珠菌

Rapid Detection and Differentiation of Clinically Relevant Candida Species Simultaneously from Blood Culture by Use of a Novel Signal Amplification Approach.
PubMed 文献 · J Clin Microbiol · 2017-12-26

本研究开发了一种基于生物素标记聚合物介导信号放大联合靶向rRNA的多重检测平台,可直接从血培养中同时检测并鉴别7种临床相关念珠菌,在80分钟内完成且物种特异性极高,检测限为1×10^3至10×10^3 CFU/ml或每检测低至50 CFU。用67份临床样本验证,与MALDI质谱参考结果总体一致率为100%。

要点

  • 该多重检测平台可在80分钟内同时检测并鉴别7种临床相关念珠菌。
  • 检测限为1×10^3至10×10^3 CFU/ml或每检测低至50 CFU。
  • 67份临床样本验证与MALDI质谱参考结果总体一致率为100%。

核心结论

  • 该新型信号放大多重检测平台可快速、特异性地从血培养中检测并鉴别7种临床相关念珠菌,与MALDI质谱参考结果总体一致率为100%。

研究设计与样本

  • 本研究为检测平台开发与验证研究,采用生物素标记聚合物介导信号放大联合靶向rRNA的多重检测方法,用67份临床样本(包括混合多种念珠菌感染样本)进行性能验证,并与MALDI质谱参考结果比较。

主要发现

  • 该检测可同时检测7种致病念珠菌(白色念珠菌、光滑念珠菌、近平滑念珠菌、热带念珠菌、克柔念珠菌、葡萄牙念珠菌和季也蒙念珠菌),物种水平特异性极高,检测时间少于80分钟。
  • 检测限为1×10^3至10×10^3 CFU/ml或每检测低至50 CFU。
  • 67份临床样本验证中,该检测与MALDI质谱参考结果总体一致率为100%。

临床怎么用

  • 该检测可快速提供物种鉴定信息,有助于临床医生比现有方法(包括基于PCR的检测)更早、更准确地指导适当治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fungal bloodstream infections are a significant problem in the United States, with an attributable mortality rate of up to 40%. An early diagnosis to direct appropriate therapy has been shown to be critical to reduce mortality rates. Conventional phenotypic methods for fungal detection take several days, which is often too late to impact outcomes. Herein, we describe a cost-effective multiplex assay platform for the rapid detection and differentiation of major clinically relevant Candida species directly from blood culture. This approach utilizes a novel biotin-labeled polymer-mediated signal amplification process combined with targeting rRNA to exploit phylogenetic differences for sensitive and unambiguous species identification; this assay detects seven pathogenic Candida species (C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, C. lusitaniae, and C. guilliermondii) simultaneously with very high specificity to the species level in less than 80 min with the limits of detection at 1 × 103 to 10 × 103 CFU/ml or as few as 50 CFU per assay. The performance of the described assay was verified with 67 clinical samples (including mixed multiple-species infections as well), with an overall 100% agreement with matrix-assisted laser desorption ionization (MALDI) mass spectrometry-based reference results. By providing a species identity rapidly, the clinician is aided with information that may direct appropriate therapy sooner and more accurately than current approaches, including PCR-based tests.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Ao W, Klonoski J, Berlinghoff E, et al. Rapid Detection and Differentiation of Clinically Relevant Candida Species Simultaneously from Blood Culture by Use of a Novel Signal Amplification Approach. J Clin Microbiol. 2017. PMID: 29046411. doi:10.1128/JCM.00982-17

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。